. These tests may provide a specific etiological diagnosis before blood cultures are identified to be positive in bacteremic infections (2, 6). Elevated levels of staphylococcal antibodies beyond the normal range also distinguish S. aureus bacteremia complicated by endocarditis or metastatic infection from uncomplicated bacteremia associated with infected intravascular devices, thus providing useful information in determining the duration of antibiotic therapy (7, 12, (15) (16) (17) (ii) Solid-phase radioimmunoassay. Solid-phase radioimmunoassay has been described previously (16, 17) . Briefly, polystyrene tubes were coated with 0.2 ml of an ultrasonic extract of the Wood 46 strain of S. aureus diluted in 0.01 M Tris-hydrochloride buffer (pH 7.0) for 1 h at 37°C. Next, 0.2 ml of 5% bovine serum albumin in the 0.01 M Tris-hydrochloride buffer was incubated for 1 h at 37°C. Then 0.2 ml of sera diluted in 0.10 M Tris-saline (pH 8.0) with 5% bovine serum albumin (1/300 for the immunoglobulin M [IgM] assay and 1/3,000 for the IgG assay) was incubated in the antigencoated tubes for 1 h at 37°C. Finally, 0.2 ml of 125I-labeled goat IgG anti-human IgG at a concentration of about 2 ,ug/ml 764
We have evaluated serological tests for the diagnosis of Staphylococcus aureus osteomyelitis. Antiteichoic acid antibodies were elevated in 17 of 23 patients with acute and 16 of 46 with chronic S. aureus osteomyelitis but in none of 33 patients infected with other gram-positive or gram-negative bacteria. Immunoglobulin G antibodies to S. aureus were elevated in 12 of 23 patients with acute and 22 of 47 with chronic S. aureus osteomyelitis, in 2 of 12 infected with other gram-positive bacteria, and in 4 of 21 with other gram-negative bacteria. Assays for S. aureus antibodies may be useful for identifying patients with S. aureus bacteremia complicated by metastatic sites of infection in bone and for identifying the etiological agents in patients with negative or mixed cultures or from whom cultures are not readily available. Prospective studies are needed to test these hypotheses.
Identification of the etiological agent in osteomyelitis may be difficult. In some patients with acute osteomyelitis blood cultures may be negative, thus necessitating bone biopsy to establish a diagnosis (3, 13 (14) . Organisms isolated from these specimens may only represent colonization of the superficial site (5, 8) , and less frequently the causative agent may not be identified in cultures from the sinus or wound (5 (2, 6, 7, 11, 12, (15) (16) (17) . These tests may provide a specific etiological diagnosis before blood cultures are identified to be positive in bacteremic infections (2, 6) . Elevated levels of staphylococcal antibodies beyond the normal range also distinguish S. aureus bacteremia complicated by endocarditis or metastatic infection from uncomplicated bacteremia associated with infected intravascular devices, thus providing useful information in determining the duration of antibiotic therapy (7, 12, (15) (16) (17) (ii) Solid-phase radioimmunoassay. Solid-phase radioimmunoassay has been described previously (16, 17) . Briefly, polystyrene tubes were coated with 0.2 ml of an ultrasonic extract of the Wood 46 strain of S. aureus diluted in 0.01 M Tris-hydrochloride buffer (pH 7.0) for 1 h at 37°C. Next, 0.2 ml of 5% bovine serum albumin in the 0.01 M Tris-hydrochloride buffer was incubated for 1 h at 37°C. Then 0. other. IgG antibodies were increased in 4 of 21 (19.0%) patients with gram-negative osteomyelitis; two of these patients were intravenous drug addicts with P. aeruginosa osteomyelitis, one was diabetic with M. morganii osteomyelitis related to chronic foot ulcers, and the final patient had Proteus mirabilis osteomyelitis. DISCUSSION S. aureus is the most common cause of osteomyelitis, isolated in about 60% of cases of acute and chronic osteomyelitis (3, 5, 13) . Successful antibiotic therapy requires a prompt and accurate diagnosis (13, 14) . Delayed diagnosis and therapy of acute staphylococcal osteomyelitis may be one factor responsible for progression to chronic osteomyelitis (1, 4) . Failure to identify S. aureus as the cause of chronic osteomyelitis in patients with mixed cultures of sinus tract drainage or open wounds may result in inadequate therapy and treatment failure.
Serological tests measuring the antibody response to S. aureus could assist in identifying the etiological agent in osteomyelitis. In our patients with acute S. aureus osteomyelitis teichoic acid antibodies were elevated in 74%, whereas IgG antibodies to the ultrasonic extract were present in 52%. Nearly 80% of these patients were bacteremic. In chronic S. aureus osteomyelitis elevated titers of teichoic acid antibodies were present in 35% of our patients, whereas IgG antibodies were detected by radioimmunoassay in 47%.
False-positive results occurred only by radioimmunoassay. The radioimmunoassay is more sensitive than our immunodiffusion method, explaining its higher false-positivity rate. Infecting organisms in these patients included P. aeruginosa in four and Enterococcus sp., Propionibacterium acnes, M. morganii, and Proteus mirabilis in one patient each. Of the six controls with gram-negative osteomyelitis and high levels of IgM or IgG antibodies to S. aureus, four were intravenous drug addicts and another was a diabetic with chronic foot infections, groups recognized to be at risk for staphylococcal skin colonization and infection (9, 10). Thus, positive results in these individuals were possibly caused by prior staphylococcal infection rather than by cross-reactivity due to shared antigens.
In conclusion, antibodies to a variety of staphylococcal antigens develop in 73% of patients with acute and 47% with chronic osteomyelitis caused by S. aureus. The serological response could be useful for identifying S. aureus as the etiological agent in acute osteomyelitis before blood culture results were known or in patients with negative cultures. Also, elevated staphylococcal antibodies in patients with S. aureus bacteremia would support a search for metastatic sites of infection in bone, since a 4-to 6-week course of parenteral antibiotic therapy would be necessary in these individuals (7, 15, 17 
